Bayesian Design and Analysis of Active Control Clinical Trials
From MaRDI portal
Recommendations
Cited in
(13)- Bayesian design for clinical trials with a constraint on the total available dose
- scientific article; zbMATH DE number 4155731 (Why is no real title available?)
- Bayesian models and methods in public policy and government settings
- A Bayesian Group Sequential Approach for Multiple Endpoints
- Some remarks about the analysis of active control studies
- A more powerful test for three-arm non-inferiority via risk difference: Frequentist and Bayesian approaches
- Bayesian multi-arm de-intensification designs
- Using historical control information for the design and analysis of clinical trials with overdispersed count data
- Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin
- Assessing overall evidence from noninferiority trials with shared historical data
- Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?
- Bayesian sample size determination for detecting heterogeneity in multi-site replication studies
- Bayesian design of noninferiority trials for medical devices using historical data
This page was built for publication: Bayesian Design and Analysis of Active Control Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4666591)